MapLight Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MapLight Therapeutics (Nasdaq: MPLT) announced management will participate in two investor conferences in New York: the RBCCM Global Healthcare Conference on May 19, 2026, and the Jefferies Global Healthcare Conference on June 3, 2026.

Management will present and host 1x1 meetings; live webcasts and archived recordings will be posted on the company’s Events & Presentations investor page.

News Market Reaction – MPLT

-6.16%

4 alerts

-6.16% Session close to close

$1.16B Market Cap

0.3x Rel. Volume

In the May 8 session, MPLT declined 6.16%, reflecting a notable negative market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN FRANCISCO and BOSTON, May 08, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences:

Event: 2026 RBCCM Global Healthcare Conference (New York, NY)
Date: Tuesday, May 19^th
Format: Presenting and hosting 1x1 meetings

Event: 2026 Jefferies Global Healthcare Conference (New York, NY)
Date: Wednesday, June 3^rd
Format: Presenting and hosting 1x1 meetings

Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the “Events & Presentations” page on the Investor section of the company’s website at https://ir.maplightrx.com/news-events/events-presentations.

About MapLight Therapeutics

MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The Company’s discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. For more information, please visit www.maplightrx.com.

For investor inquiries: investors@maplightrx.com

For media inquiries: media@maplightrx.com

FAQ

When will MapLight Therapeutics (MPLT) present at the RBCCM Global Healthcare Conference?

MapLight will present on May 19, 2026 and host one-on-one investor meetings. According to MapLight Therapeutics, management will offer a live webcast and archived recording on the company’s Events & Presentations investor page.

What format will MapLight Therapeutics use at the Jefferies Global Healthcare Conference (MPLT) on June 3, 2026?

MapLight will present and host 1x1 meetings at the June 3, 2026 event. According to MapLight Therapeutics, where available a live webcast and archived recording will be posted on the company’s investor Events & Presentations page.

How can investors watch MapLight Therapeutics (MPLT) webcasts from these conferences?

Investors can access live webcasts and archived recordings on the company’s investor website Events & Presentations page. According to MapLight Therapeutics, links and recordings will be posted when available at https://ir.maplightrx.com/news-events/events-presentations.

Who from MapLight Therapeutics (MPLT) will attend the May–June 2026 investor conferences?

Members of MapLight’s management team will attend and present at both conferences. According to MapLight Therapeutics, management will both present onstage and host one-on-one investor meetings at the listed events.

Will MapLight Therapeutics (MPLT) offer on-demand recordings after the RBCCM and Jefferies conferences?

Yes; archived recordings will be posted on the company’s investor Events & Presentations page after the events. According to MapLight Therapeutics, availability details and webcast links will appear on the investor website when ready.